Harvard Bioscience, Inc. announced the appointment of John Duke to its board of directors effective June 2, 2025, where he will also participate in the audit and nominating and governance committees.

HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Monday reported a loss of $2.3 million in its second quarter. The Holliston, Massachusetts-based company said it had a ...

Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.025. Operator: Good day, and welcome to the Second Quarter 2025 Harvard Bioscience Earnings ...

The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...

Harvard Bioscience, a Holliston-based biotech firm, has fallen out of compliance with Nasdaq stock exchange requirements following the resignation of a board of directors member. After the June 10 ...

Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by Operations Company Expects to Refinance or Repay the Debt in the Fourth Quarter Fourth Quarter 2025 Guidance ...